医療用食品のアジア太平洋市場2022~2030:投与経路別、製品タイプ別、用途別、販売チャネル別、地域別

■ 英語タイトル:Asia Pacific Medical Foods Market Size, Share & Trends Analysis Report By Route Of Administration, By Product Type, By Application, By Sales Channel, By Region, And Segment Forecasts, 2022 - 2030

調査会社Grand View Research社が発行したリサーチレポート(データ管理コード:GRV22JL004)■ 発行会社/調査会社:Grand View Research
■ 商品コード:GRV22JL004
■ 発行日:2022年5月18日
■ 調査対象地域:アジア太平洋
■ 産業分野:医薬品
■ ページ数:150
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後3営業日)
■ 販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[医療用食品のアジア太平洋市場2022~2030:投与経路別、製品タイプ別、用途別、販売チャネル別、地域別]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

グランドビューリサーチ社は、アジア太平洋の医療用食品市場規模が2022年から2030年までの間に年平均6.4%成長し、2030年までに99億ドルに達すると予測しています。本調査レポートでは、医療用食品のアジア太平洋市場について調査し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、投与経路別分析、製品別分析、用途別分析、販売チャネル別分析、地域別分析、競争状況など、以下の構成でお届け致します。本調査レポートでは、Mead Johnson、SHS International Ltd、Synutra International Ltd、Nestle、Milupa GmbH、Danone、GlaxoSmithKline, PLC、Fresenius Kabi AG、Abbotなどの企業情報が含まれております。

アジア太平洋の医療用食品市場の成長と動向
Grand View Research社の最新レポートによると、アジア太平洋の医療用食品市場規模は2030年までに99億米ドルに達すると予測されています。同市場は2022年から2030年にかけて年平均成長率6.4%で成長する見込みです。都市化の急速な進展と老年人口の増加により、高齢者や座りがちなライフスタイルの人が罹患する疾患の管理ニーズが高まっています。

投与経路に基づくと、経口セグメントは2021年に69.0%の最大の収益シェアを占めました。入手可能な医療用食品の大半は経口摂取用です。投与が容易で消費者の需要が高まっていることが、このセグメントの最大市場シェアに寄与しています。経腸投与経路は、2022年から2030年にかけて最も速いCAGR 6.8%を記録しました。経口摂取が不可能な疾病に罹患する人口の増加が、この成長をもたらしています。経腸栄養は、栄養素の吸収が良く、汚染率が低いため、いくつかのケースで有効であることが証明されています。

製品タイプ別では、粉末製剤が2021年に市場で最大の収益シェアを記録しました。現在市場で入手可能な製品の大半は粉末製剤です。保存が容易で賞味期限が長いことが、この製品タイプが広く採用される主な要因の1つです。主要プレーヤーがより多くの人口に対応するために製品ポートフォリオを多様化しているため、液体製剤セグメントは予測期間中に最も速い成長を記録すると予想されます。このセグメントは、医療食品業界において最大の成長ポテンシャルを有すると予想されます。

2021年には、がんの負担が大きく、適切な管理が必要なことから、化学療法による下痢が用途別セグメントで最大の収益シェアを占めました。医療用食品を通じた栄養補給は癌の管理において必要となっており、このためこのセグメントにおける医療用食品の需要の伸びが促進されています。糖尿病性神経障害セグメントは、予測期間中に最も速い CAGR を記録すると予想されます。これは、急速に発展しているアジア太平洋(APAC)諸国におけるこの疾患の有病率の上昇と、この疾患の管理のための栄養豊富な食品に対する需要の増加によるものです。

2021年には、施設販売が販売チャネル・セグメントで最大の収益シェアを占めました。APACはまだ成長の大きな可能性を秘めた未開拓の領域であり、医療用食品の主な購入チャネルは、製品の流通のために市場プレーヤーが雇う医療担当者に依存する診療所や保健センターの医師を通じてです。オンライン・プラットフォームは、疾病管理における医療用食品の利点についての認識が高まっていることから、今後数年間で CAGR が最も速くなると予想されます。主要な市場参入企業は、流通チャネルを多様化し、医療用食品をオンラインで消費者に直接販売するために協力することで、リーチを拡大しています。

COVID-19 パンデミックは APAC の医療用食品市場の成長に悪影響を及ぼしました。というのも、同市場の医療用食品の大半は他国から輸入されており、貿易規制が敷かれたことでサプライ・チェーンが深刻な影響を受けたからです。人々の健康状態の悪化と高齢者人口の増加により、これらの製品に対する需要が増加しているため、市場は回復すると予想されます。

アジア太平洋の医療用食品市場レポートハイライト

- 製品タイプの入手可能性が高く、投与が容易であることから、経口投与経路が2021年に69%の最大売上シェアを獲得しました。

- 製品タイプ別では、使いやすさと製品の入手可能性の高さから粉末製剤が35.4%の最大売上シェアを獲得しました。

- 糖尿病性神経障害は、2022〜2030年の予測期間中、用途別セグメントで最速の成長が見込まれます。高い疾病負担と適切な疾病管理の必要性が成長の主要因です。

- 市場シェアは施設販売チャネルが最も高く、オンライン販売チャネルは、認知度の向上とオンライン販売を通じてより広い範囲にリーチするためのプレイヤーの主要な取り組みにより、予測期間中に最も速い速度で拡大する見込みです。

*** レポート目次(コンテンツ)***

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Research Methodology
1.2.1 Information Procurement
1.2.1.1 Purchased database:
1.2.1.2 GVR’s internal database
1.2.2 Primary Research:
1.2.3 Research Methodology:
1.3 Research Scope and Assumptions
1.4 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Asia Pacific Medical Foods Market Snapshot
Chapter 3 Asia Pacific Medical Foods Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.1.1 Nutritional Supplements Market
3.1.2 Ancillary Market Outlook
3.1.2.1 Parenteral Nutrition market:
3.1.2.2 Enteral Feeding Devices Market
3.2 Penetration and Growth Prospect Mapping
3.3 Pricing Analysis
3.4 User Perspective Analysis
3.4.1 Consumer Behavior Analysis
3.4.2 Market Influencer Analysis
3.4.3 Key End Users
3.5 Technology Outlook
3.5.1 Technology Timeline
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.2 Market Restraint Analysis
3.6.3 Industry Challenges
3.7 Asia Pacific Medical Foods Market Analysis Tools
3.7.1 Asia Pacific Medical Foods Market – Pestle Analysis
3.7.2 Industry Analysis – Porter’s
3.8 Major Deals & Strategic Alliances Analysis
3.9 Market Entry Strategies
3.10 Prevalence of Health Conditions in Asia Pacific (2016-2030)
3.10.1 Chronic Kidney Disease
3.10.2 Minimal Hepatic Encephalopathy
3.10.3 Chemotherapy-Induced Diarrhea
3.10.4 Pathogen Related Infections
3.10.5 Diabetic Neuropathy
3.10.6 ADHD
3.10.7 Depression
3.10.8 Alzheimer’s Disease
3.10.9 Nutritional Deficiency
3.10.10 Chronic Wound
3.10.11 Chronic Diarrhea
3.10.12 Constipation
3.10.13 Dysphagia (Swallowing Disorder)
3.10.14 Orphan Diseases
3.10.14.1 Phenylketonuria
3.10.14.2 Eosinophilic Esophagitis
3.10.14.3 FPIES
3.10.14.4 Others
3.11 Impact of COVID-19 on Asia Pacific Medical Foods Market
Chapter 4 Asia Pacific Medical Foods Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Company Market Share Analysis, 2021
4.4 Public Companies
4.4.1 Company Market Position Analysis
4.4.2 Company Market Ranking By Region
4.5 Private Companies
4.5.1 Regional Map
4.5.2 Company Market Position Analysis
Chapter 5 Asia Pacific Medical Foods Market: Route of Administration Estimates & Trend Analysis
5.1 Asia Pacific Medical Foods Market: Route of Administration (ROA) Movement Analysis, 2021 & 2030, USD Million
5.2 Oral
5.2.1 Oral Medical Foods Market Estimates And Forecasts, 2016 – 2030 (USD Million)
5.3 Enteral
5.3.1 Enteral Medical Foods Market Estimates And Forecasts, 2016 – 2030 (USD Million)
Chapter 6 Asia Pacific Medical Foods Market: Products Estimates & Trend Analysis
6.1 Asia Pacific Medical Foods Market: Product Movement Analysis, 2021 & 2030, USD Million
6.2 Pills
6.2.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Pills Formulation, 2016 – 2030 (USD Million)
6.3 Powder
6.3.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Powder Formulation, 2016 – 2030 (USD Million)
6.4 Others
6.4.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Other Formulations, 2016 – 2030 (USD Million)
Chapter 7 Asia Pacific Medical Foods Market: Application Estimates & Trend Analysis
7.1 Asia Pacific Medical Foods Market: Application Movement Analysis, 2021 & 2030, USD Million
7.2 Chronic Kidney Diseases
7.2.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Chronic Kidney Diseases, 2016 – 2030 (USD Million)
7.3 Minimal Hepatic Encephalopathy
7.3.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Minimal Hepatic Encephalopathy, 2016 – 2030 (USD Million)
7.4 Chemotherapy-Induced Diarrhea
7.4.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Chemotherapy-Induced Diarrhea, 2016 – 2030 (USD Million)
7.5 Pathogen Related Infection
7.5.1 Asia Pacific medical foods market estimates and forecasts for pathogen-related infections, 2016 – 2030 (USD Million)
7.6 Diabetic Neuropathy
7.6.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Diabetic Neuropathy, 2016 – 2030 (USD Million)
7.7 ADHD
7.7.1 Asia Pacific Medical Foods Market Estimates And Forecasts For ADHD, 2016 – 2030 (USD Million)
7.8 Depression
7.8.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Depression, 2016 – 2030 (USD Million)
7.9 Alzheimer’s Disease
7.9.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Alzheimer’s Disease, 2016 – 2030 (USD Million)
7.10 Nutritional Deficiency
7.10.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Nutritional Deficiency, 2016 – 2030 (USD Million)
7.11 Orphan Diseases
7.11.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Orphan Diseases, 2016 – 2030 (USD Million)
7.11.2 Phenylketonuria
7.11.2.1 Asia Pacific Medical foods market estimates and Forecasts for Phenylketonuria, 2016 – 2030 (USD Million)
7.11.3 Eosinophilic Esophagitis
7.11.3.1 Asia Pacific Medical foods market estimates and Forecasts for Eosinophilic Esophagitis, 2016 – 2030 (USD Million)
7.11.4 FPIES
7.11.4.1 Asia Pacific Medical foods market estimates and Forecasts for FPIES, 2016 – 2030 (USD Million)
7.11.5 Other Orphan Diseases
7.11.5.1 Asia Pacific Medical foods market estimates and Forecasts for Other orphan diseases, 2016 – 2030 (USD Million)
7.12 Wound Healing
7.12.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Wound Healing, 2016 – 2030 (USD Million)
7.13 Chronic Diarrhea
7.13.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Chronic Diarrhea, 2016 – 2030 (USD Million)
7.14 Constipation Relief
7.14.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Constipation Relief, 2016 – 2030 (USD Million)
7.15 Protein Booster
7.15.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Protein Booster, 2016 – 2030 (USD Million)
7.16 Dysphagia
7.16.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Dysphagia, 2016 – 2030 (USD Million)
7.17 Other Diseases
7.17.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Other Diseases, 2016 – 2030 (USD Million)
7.17.2 Parkinson’s Disease
7.17.2.1 Asia Pacific Medical foods market estimates and Forecasts for Parkinson’s Disease, 2016 – 2030 (USD Million)
7.17.3 Epilepsy
7.17.3.1 Asia Pacific Medical foods market estimates and Forecasts for Epilepsy, 2016 – 2030 (USD Million)
7.17.4 Pain Management
7.17.4.1 Asia Pacific Medical foods market estimates and Forecasts for Pain Management, 2016 – 2030 (USD Million)
7.17.5 Other Cancer Related Treatments
7.17.5.1 Asia Pacific Medical foods market estimates and Forecasts for Other Cancer Related Treatments, 2016 – 2030 (USD Million)
Chapter 8 Asia Pacific Medical Foods Market: Sales Channel Estimates & Trend Analysis
8.1 Asia Pacific Medical Foods Market: Sales Channel Movement Analysis, 2021 & 2030, USD Million
8.2 Online Sales
8.2.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Online Sales Channel, 2016 – 2030 (USD Million)
8.3 Retail Sales
8.3.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Retail Sales Channel, 2016 – 2030 (USD Million)
8.4 Institutional Sales
8.4.1 Asia Pacific Medical Foods Market Estimates And Forecasts For Institutional Sales Channel, 2016 – 2030 (USD Million)
Chapter 9 Asia Pacific Medical Foods Market: Regional Estimates and Trend Analysis, by Route of Administration, Product, Payment Scheme, Application, & Sales Channel
9.1 Asia Pacific Medical Foods Market: Regional Movement Analysis, 2020 & 2030, USD Million
9.2 Asia Pacific
9.2.1 Asia Pacific Medical Foods Market Estimates And Forecasts, 2016 – 2030 (USD Million)
9.2.2 Japan
9.2.2.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.3 China
9.2.3.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.4 Australia
9.2.4.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.5 New Zealand
9.2.5.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.6 India
9.2.6.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.7 Singapore
9.2.7.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
9.2.8 South Korea
9.2.8.1 Market estimates and forecasts, by route of administration, product type, application, and sales channel, 2016 – 2030 (USD Million)
Chapter 10 Competitive Landscape
10.1 Company Profiles
10.1.1 Mead Johnson
10.1.1.1 Company Overview
10.1.1.2 Financial Performance
10.1.1.3 Product Benchmarking
10.1.1.4 Strategic Initiatives
10.1.2 SHS International Ltd
10.1.2.1 Company Overview
10.1.2.2 Financial Performance
10.1.2.3 Product Benchmarking
10.1.2.4 Strategic Initiatives
10.1.3 Synutra International Ltd
10.1.3.1 Company Overview
10.1.3.2 Financial Performance
10.1.3.3 Product Benchmarking
10.1.3.4 Strategic Initiatives
10.1.4 Nestle
10.1.4.1 Company Overview
10.1.4.2 Financial Performance
10.1.4.3 Product Benchmarking
10.1.4.4 Strategic Initiatives
10.1.5 Milupa GmbH
10.1.5.1 Company Overview
10.1.5.2 Financial Performance
10.1.5.3 Product Benchmarking
10.1.5.4 Strategic Initiatives
10.1.6 Danone
10.1.6.1 Company Overview
10.1.6.2 Financial Performance
10.1.6.3 Product Benchmarking
10.1.6.4 Strategic Initiatives
10.1.7 GlaxoSmithKline, PLC
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 product benchmarking
10.1.7.4 Strategic Initiatives
10.1.8 Fresenius Kabi AG
10.1.8.1 Company Overview
10.1.8.2 Financial Performance
10.1.8.3 Product Benchmarking
10.1.8.4 Strategic Initiatives
10.1.9 Abbot
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 product benchmarking
10.1.9.4 Strategic Initiatives

List of Tables

TABLE 1 List of secondary data
TABLE 2 Asia Pacific medical foods market, by country, 2016 - 2030 (USD Million)
TABLE 3 Asia Pacific medical foods market, by route of administration, 2016 - 2030 (USD Million)
TABLE 4 Asia Pacific medical foods market, by product type, 2016 - 2030 (USD Million)
TABLE 5 Asia Pacific medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 6 Asia Pacific orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 7 Asia Pacific medical foods market, by sales channel, 2016 - 2030 (USD Million)
TABLE 8 Japan medical foods market, by route of administration, 2016 - 2030 (USD Million)
TABLE 9 Japan medical foods market, by product type, 2016 - 2030 (USD Million)
TABLE 10 Japan medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 11 Japan orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 12 Japan medical foods market, by sales channel, 2016 - 2030 (USD Million)
TABLE 13 China medical foods market, by route of administration, 2016 - 2030 (USD Million)
TABLE 14 China medical foods market, by product type, 2016 - 2030 (USD Million)
TABLE 15 China medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 16 China orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 17 China medical foods market, by sales channel, 2016 - 2030 (USD Million)
TABLE 18 Australia medical foods market, by route of administration, 2016 - 2030 (USD Million)
TABLE 19 Australia medical foods market, by product type, 2016 - 2030 (USD Million)
TABLE 20 Australia medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 21 Australia orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 22 Australia medical foods market, by sales channel, 2016 - 2030 (USD Million)
TABLE 23 New Zealand medical foods market, by route of administration, 2016 - 2030 (USD Million)
TABLE 24 New Zealand medical foods market, by product type, 2016 - 2030 (USD Million)
TABLE 25 New Zealand medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 26 New Zealand orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 27 New Zealand medical foods market, by sales channel, 2016 - 2030 (USD Million)
TABLE 28 India medical foods market, by route of administration, 2016 - 2030 (USD Million)
TABLE 29 India medical foods market, by product type, 2016 - 2030 (USD Million)
TABLE 30 India medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 31 India orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 32 India medical foods market, by sales channel, 2016 - 2030 (USD Million)
TABLE 33 Singapore medical foods market, by route of administration, 2016 - 2030 (USD Million)
TABLE 34 Singapore medical foods market, by product type, 2016 - 2030 (USD Million)
TABLE 35 Singapore medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 36 Singapore orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 37 Singapore medical foods market, by sales channel, 2016 - 2030 (USD Million)
TABLE 38 South Korea medical foods market, by route of administration, 2016 - 2030 (USD Million)
TABLE 39 South Korea medical foods market, by product type, 2016 - 2030 (USD Million)
TABLE 40 South Korea medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 41 South Korea orphan diseases specific medical foods market, by application, 2016 - 2030 (USD Million)
TABLE 42 South Korea medical foods market, by sales channel, 2016 - 2030 (USD Million)


List of Figures

FIG. 1 Asia Pacific medical foods market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Asia Pacific medical foods market summary, 2021 (USD Million)
FIG. 6 Medical foods market trends & outlook
FIG. 7 Parent market analysis, 2021
FIG. 8 Company market share analysis, 2021
FIG. 9 Company market position analysis
FIG. 10 Company market ranking, by region
FIG. 11 Regional Map
FIG. 12 Company market position analysis
FIG. 13 Asia Pacific Medical foods market, route of administration outlook: Key takeaways, USD Million
FIG. 14 Asia Pacific medical foods market: ROA movement analysis, 2021 & 2030 (USD Million)
FIG. 15 Oral medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 16 Enteral medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 17 Asia Pacific medical foods market, product type outlook: Key takeaways, USD Million
FIG. 18 Asia Pacific medical foods market: Product type movement analysis, 2021 & 2030 (USD Million)
FIG. 19 Asia Pacific medical foods market estimates and forecasts for pills formulation, 2016 - 2030 (USD Million)
FIG. 20 Asia Pacific medical foods market estimates and forecasts for powder formulation, 2016 - 2030 (USD Million)
FIG. 21 Asia Pacific medical foods market estimates and forecasts for other formulations, 2016 - 2030 (USD Million)
FIG. 22 Asia Pacific medical foods market, application outlook: Key takeaways, USD Million
FIG. 23 Asia Pacific medical foods market: application movement analysis, 2021 & 2030 (USD Million)
FIG. 24 Asia Pacific medical foods market estimates and forecasts for chronic kidney diseases, 2016 - 2030 (USD Million)
FIG. 25 Asia Pacific medical foods market estimates and forecasts for minimal hepatic encephalopathy, 2016 - 2030 (USD Million)
FIG. 26 Asia Pacific medical foods market estimates and forecasts for chemotherapy-induced diarrhea, 2016 - 2030 (USD Million)
FIG. 27 Asia Pacific medical foods market estimates and forecasts for pathogen-related infections, 2016 - 2030 (USD Million)
FIG. 28 Asia Pacific medical foods market estimates and forecasts for diabetic neuropathy, 2016 - 2030 (USD Million)
FIG. 29 Asia Pacific medical foods market estimates and forecasts for ADHD, 2016 - 2030 (USD Million)
FIG. 30 Asia Pacific medical foods market estimates and forecasts for depression, 2016 - 2030 (USD Million)
FIG. 31 Asia Pacific medical foods market estimates and forecasts for Alzheimer’s disease, 2016 - 2030 (USD Million)
FIG. 32 Asia Pacific medical foods market estimates and forecasts for nutritional deficiency, 2016 - 2030 (USD Million)
FIG. 33 Asia Pacific medical foods market estimates and forecasts for orphan diseases, 2016 - 2030 (USD Million)
FIG. 34 Asia Pacific medical foods market estimates and forecasts for phenylketonuria, 2016 - 2030 (USD Million)
FIG. 35 Asia Pacific medical foods market estimates and forecasts for eosinophilic esophagitis, 2016 - 2030 (USD Million)
FIG. 36 Asia Pacific medical foods market estimates and forecasts for FPIES, 2016 - 2030 (USD Million)
FIG. 37 Asia Pacific medical foods market estimates and forecasts for other orphan diseases, 2016 - 2030 (USD Million)
FIG. 38 Asia Pacific medical foods market estimates and forecasts for wound healing, 2016 - 2030 (USD Million)
FIG. 39 Asia Pacific medical foods market estimates and forecasts for chronic diarrhea, 2016 - 2030 (USD Million)
FIG. 40 Asia Pacific medical foods market estimates and forecasts for constipation relief, 2016 - 2030 (USD Million)
FIG. 41 Asia Pacific medical foods market estimates and forecasts for protein booster, 2016 - 2030 (USD Million)
FIG. 42 Asia Pacific medical foods market estimates and forecasts for dysphagia, 2016 - 2030 (USD Million)
FIG. 43 Asia Pacific medical foods market estimates and forecasts for other diseases, 2016 - 2030 (USD Million)
FIG. 44 Asia Pacific medical foods market estimates and forecasts for Parkinson’s disease, 2016 - 2030 (USD Million)
FIG. 45 Asia Pacific medical foods market estimates and forecasts for epilepsy, 2016 - 2030 (USD Million)
FIG. 46 Asia Pacific medical foods market estimates and forecasts for pain management, 2016 - 2030 (USD Million)
FIG. 47 Asia Pacific medical foods market estimates and forecasts for other cancer-related treatments, 2016 - 2030 (USD Million)
FIG. 48 Asia Pacific medical foods market, sales channel outlook: Key takeaways, USD Million
FIG. 49 Asia Pacific medical foods market: Sales channel movement analysis, 2020 & 2030 (USD Million)
FIG. 50 Asia Pacific medical foods market estimates and forecasts for online sales channel, 2016 - 2030 (USD Million)
FIG. 51 Asia Pacific medical foods market estimates and forecasts for retail sales channel, 2016 - 2030 (USD Million)
FIG. 52 Asia Pacific medical foods market estimates and forecasts for institutional sales channel, 2016 - 2030 (USD Million)
FIG. 53 Regional marketplace: Key takeaways
FIG. 54 Asia Pacific medical foods market: Regional movement analysis, 2021 & 2030 (USD Million)
FIG. 55 Asia Pacific medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 56 Japan medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 57 China medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 58 Australia medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 59 New Zealand medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 60 Spain medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 61 South Korea medical foods market estimates and forecasts, 2016 - 2030 (USD Million)
FIG. 62 Singapore medical foods market estimates and forecasts, 2016 - 2030 (USD Million)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GRV22JL004 )"医療用食品のアジア太平洋市場2022~2030:投与経路別、製品タイプ別、用途別、販売チャネル別、地域別" (英文:Asia Pacific Medical Foods Market Size, Share & Trends Analysis Report By Route Of Administration, By Product Type, By Application, By Sales Channel, By Region, And Segment Forecasts, 2022 - 2030)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。